Oceania Healthcare’s 2026 full-year result: $227m of unsold development stock
“It represents future cash to be released as sell-down progresses. The trajectory is what matters, and our trajectory…
Ryman Healthcare’s previous interim profit turns into a loss with lower revaluations but CEO cites corner turned
In October, it listed on the ASX. Ryman Healthcare CEO Naomi James, with Bruce Wattie, grandson of Sir…
NZX flat after Vital Healthcare’s $200m capital raising – Market close
Vital Healthcare will fund the move with a $220m capital raise through a $190m underwritten placement and $30m…